文献速递免疫规划慢病防控与筛查

头颈鳞状细胞癌中人乳头瘤病毒致癌基因的转录分析

Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas.
PubMed 文献 · Vaccine · 2020-04-30

基于TCGA中500例头颈鳞状细胞癌原发肿瘤的RNA测序数据,分析HPV致癌基因E6/E7的转录情况。113例检出HPV转录本,其中90例同时有E6和E7转录,HPV16最常见。结合美国癌症发病统计,HPV16/18/33致癌基因转录可见于约8.3%女性和20.2%男性头颈癌患者,若这些癌症由HPV引起,预防HPV16/18/33感染每年可预防美国约49 300例头颈癌。

要点

  • 头颈鳞癌中HPV致癌基因E6/E7转录常见,113/500例检出HPV转录本,90例同时有E6和E7转录。
  • HPV16 E6/E7转录67例,HPV33 14例,HPV18 6例,HPV35 5例。
  • 扁桃体肿瘤HPV致癌基因转录比例最高(34/40,85%),其次为腭(4/5,80%)、舌根(10/20,50%)、口咽(4/10,40%)和牙龈(4/11,36%)。

核心结论

  • TCGA数据库中很大比例头颈鳞癌存在HPV致癌基因转录,若这些癌症由HPV引起,预防HPV16/18/33感染每年可预防美国约49 300例头颈癌。

研究设计与样本

  • 使用癌症基因组图谱(TCGA)中500例头颈鳞状细胞癌原发肿瘤的RNA测序数据,以ViraPipe流程分析3.7太字节测序数据。

主要发现

  • 113/500例标本检出HPV转录本,90例同时有E6和E7致癌基因转录。
  • HPV16 E6/E7转录67例,HPV33 14例,HPV18 6例,HPV35 5例。
  • HPV致癌基因转录在扁桃体肿瘤中占34/40(85%),腭4/5(80%),舌根10/20(50%),口咽4/10(40%),牙龈4/11(36%)。
  • 对照美国癌症发病统计,疫苗可预防的HPV16/18/33致癌基因转录可见于约8.3%女性和20.2%男性头颈癌患者。

临床怎么用

  • 提示HPV疫苗接种可能预防部分头颈鳞癌,尤其与HPV16/18/33致癌基因转录相关的肿瘤。

局限性

  • 研究基于TCGA数据库RNA测序数据,未报告其他潜在混杂因素或验证队列。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Some head and neck cancers are caused by human papillomavirus (HPV). As HPV vaccination can prevent infection, an estimation of which HPV types have an active viral oncogene transcription in what proportion of tumors might allow estimation of the proportion of head & neck cancers preventable by HPV vaccination. We used all RNA sequencing data from primary tumors of head and neck squamous cell carcinomas from the Cancer Genome Atlas (n = 500 patients). We analysed 3.7 terabyte of sequencing data with the bioinformatics pipeline ViraPipe. Paired end reads were quality filtered using the original code and aligned to known HPV sequences. HPV transcripts were found in 113/500 specimens, with transcription of both the E6 and E7 viral oncogenes in 90 specimens. HPV16 had E6/E7 transcription in 67 cases, HPV33 in 14 cases, HPV18 in 6 cases and HPV35 in 5 cases. HPV oncogene transcription was most common in tumors from tonsils (34/40, 85%), followed by palate (4/5, 80%), base of tongue (10/20, 50%), oropharynx (4/10, 40%), and gum (4/11, 36%). Comparison to the cancer incidence statistics in the USA indicates that vaccine-preventable HPV16/18/33 oncogene transcription would be found in about 8.3% female and 20.2% male patients of head and neck cancers in the USA. Transcription of the HPV oncogenes is present in a large proportion of head and neck cancers in the TCGA database. If these cancers are caused by HPV, prevention of HPV16/18/33 infections would prevent ~49 300 annual head and neck cancer cases in the USA alone.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Bzhalava Z, Arroyo Mühr LS, Dillner J, et al. Transcription of human papillomavirus oncogenes in head and neck squamous cell carcinomas. Vaccine. 2020. PMID: 32362526. doi:10.1016/j.vaccine.2020.04.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。